The oxazolomycins: a structurally novel class of bioactive compounds.

Mark G. Moloney, Paul C. Trippier, Muhammad Yaqoob, Zhaoyang Wang

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Oxazolomycin, first isolated in 1985, is a novel bioactive compound, exhibiting potent antiviral, antibacterial and cytotoxic activity, and is now known to be the parent of a wider class of compounds. The broad-spectrum activity of oxazolomycin has been attributed to its protonophoric properties. This review outlines the isolation, structural determination, biosynthesis, bioactivity, biological mode of action and synthesis of all members of this compound class. Significantly, the oxazolomycins appear to offer not only a completely novel chemotype as a bioactive lead structure, but also a chemotype, which also exhibits an unusual biological mode of action.

Original languageEnglish (US)
Pages (from-to)181-199
Number of pages19
JournalCurrent drug discovery technologies
Volume1
Issue number3
DOIs
StatePublished - Oct 2004

Fingerprint

Antiviral Agents
diffusomycin
Lead

ASJC Scopus subject areas

  • Drug Discovery

Cite this

The oxazolomycins : a structurally novel class of bioactive compounds. / Moloney, Mark G.; Trippier, Paul C.; Yaqoob, Muhammad; Wang, Zhaoyang.

In: Current drug discovery technologies, Vol. 1, No. 3, 10.2004, p. 181-199.

Research output: Contribution to journalArticle

Moloney, Mark G. ; Trippier, Paul C. ; Yaqoob, Muhammad ; Wang, Zhaoyang. / The oxazolomycins : a structurally novel class of bioactive compounds. In: Current drug discovery technologies. 2004 ; Vol. 1, No. 3. pp. 181-199.
@article{294fa671f15141b2b0c4a2991ac85b47,
title = "The oxazolomycins: a structurally novel class of bioactive compounds.",
abstract = "Oxazolomycin, first isolated in 1985, is a novel bioactive compound, exhibiting potent antiviral, antibacterial and cytotoxic activity, and is now known to be the parent of a wider class of compounds. The broad-spectrum activity of oxazolomycin has been attributed to its protonophoric properties. This review outlines the isolation, structural determination, biosynthesis, bioactivity, biological mode of action and synthesis of all members of this compound class. Significantly, the oxazolomycins appear to offer not only a completely novel chemotype as a bioactive lead structure, but also a chemotype, which also exhibits an unusual biological mode of action.",
author = "Moloney, {Mark G.} and Trippier, {Paul C.} and Muhammad Yaqoob and Zhaoyang Wang",
year = "2004",
month = "10",
doi = "10.2174/1570163043334974",
language = "English (US)",
volume = "1",
pages = "181--199",
journal = "Current Drug Discovery Technologies",
issn = "1570-1638",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - The oxazolomycins

T2 - a structurally novel class of bioactive compounds.

AU - Moloney, Mark G.

AU - Trippier, Paul C.

AU - Yaqoob, Muhammad

AU - Wang, Zhaoyang

PY - 2004/10

Y1 - 2004/10

N2 - Oxazolomycin, first isolated in 1985, is a novel bioactive compound, exhibiting potent antiviral, antibacterial and cytotoxic activity, and is now known to be the parent of a wider class of compounds. The broad-spectrum activity of oxazolomycin has been attributed to its protonophoric properties. This review outlines the isolation, structural determination, biosynthesis, bioactivity, biological mode of action and synthesis of all members of this compound class. Significantly, the oxazolomycins appear to offer not only a completely novel chemotype as a bioactive lead structure, but also a chemotype, which also exhibits an unusual biological mode of action.

AB - Oxazolomycin, first isolated in 1985, is a novel bioactive compound, exhibiting potent antiviral, antibacterial and cytotoxic activity, and is now known to be the parent of a wider class of compounds. The broad-spectrum activity of oxazolomycin has been attributed to its protonophoric properties. This review outlines the isolation, structural determination, biosynthesis, bioactivity, biological mode of action and synthesis of all members of this compound class. Significantly, the oxazolomycins appear to offer not only a completely novel chemotype as a bioactive lead structure, but also a chemotype, which also exhibits an unusual biological mode of action.

UR - http://www.scopus.com/inward/record.url?scp=33645084821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645084821&partnerID=8YFLogxK

U2 - 10.2174/1570163043334974

DO - 10.2174/1570163043334974

M3 - Article

C2 - 16472256

AN - SCOPUS:33645084821

VL - 1

SP - 181

EP - 199

JO - Current Drug Discovery Technologies

JF - Current Drug Discovery Technologies

SN - 1570-1638

IS - 3

ER -